-
1
المؤلفون: Andrej Janez, Manfredi Rizzo, Djordje S. Popovic, Anca Pantea Stoian, Nikolaos Papanas, Ali A. Rizvi
المساهمون: Popovic D.S., Papanas N., Pantea Stoian A., Rizvi A.A., Janez A., Rizzo M.
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), 1 receptor agonists, Sodium-glucose co-transporter , Endocrinology, Diabetes and Metabolism, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19, Dipeptidyl peptidase , Review, Type 2 diabetes, Sodium-glucose co-transporter 2 inhibitors, Glucagon-like peptide 1 receptor agonists, Diabetes mellitus, Pandemic, Internal Medicine, medicine, 2 diabetes, Intensive care medicine, Antidiabetic agents, 4 inhibitors, Glucagon-like peptide , business.industry, COVID-19, medicine.disease, Systemic inflammatory response syndrome, Shock (circulatory), Dipeptidyl peptidase 4 inhibitors, medicine.symptom, business, 2 inhibitors, Type 
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5299514d22a08c56c16759e41199dfebTest
https://doi.org/10.1007/s13300-021-01170-3Test -
2
المؤلفون: Afshin Salsali, João Pedro Ferreira, Mitchell A. Psotka, Martina Brueckmann, Mikhail Kosiborod, Jan Biegus, Adriaan A. Voors, Claudia Grauer, Christiane E. Angermann, John R. Teerlink, Jon Blatchford, Sean P. Collins, Piotr Ponikowski, Michael E. Nassif, Jasper Tromp
المساهمون: Cardiovascular Centre (CVC), University Medical Center Groningen [Groningen] (UMCG), Duke-NUS Medical School [Singapore], National Heart Centre Singapore (NHCS), University of Wrocław [Poland] (UWr), Boehringer Ingelheim Pharma GmbH & Co. KG, Rutgers, The State University of New Jersey [New Brunswick] (RU), Rutgers University System (Rutgers), University Hospital of Würzburg, Boehringer Ingelheim International GmbH, Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Saint Luke's Mid America Heart Institute, University of New South Wales [Sydney] (UNSW), Inova Heart and Vascular Institute, Falls Church, Medizinische Fakultät Mannheim, University of California [San Francisco] (UCSF), University of California, Veterans Affairs Medical Center, San Francisco, California, The EMPULSE trial is funded by the Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance.
المصدر: European Journal of Heart Failure, 23(5), 826-834. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, Oxford University Press (OUP), 2021, ⟨10.1002/ejhf.2137⟩مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, Trial design, medicine.medical_specialty, Asia, Acute decompensated heart failure, Heart failure, 030204 cardiovascular system & hematology, Placebo, Sodium–glucose co‐transporter 2 inhibitors, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Sodium-Glucose Transporter 2, glucose co‐, Diabetes mellitus, Internal medicine, Empagliflozin, medicine, Humans, In patient, Sodium–, Study Design, Ejection fraction, business.industry, Sodium, Stroke Volume, medicine.disease, 3. Good health, Europe, Glucose, Kansas City Cardiomyopathy Questionnaire, North America, Cardiology and Cardiovascular Medicine, business, transporter 2 inhibitors
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8002ded798854384daa4260943d936eaTest
https://doi.org/10.1002/ejhf.2137Test -
3
المؤلفون: Beata Jacuś, Mirosława Kowalkowska, Paweł Miękus, Grzegorz Grześk
المصدر: Farmacja Polska, Vol 77, Iss 8, Pp 516-521 (2021)
مصطلحات موضوعية: Pharmacology, medicine.medical_specialty, sodium glucose co-transporter inhibitors, Urinary infection, type 2 diabetes mellitus, business.industry, Sodium, Pharmaceutical Science, chemistry.chemical_element, Transporter, Gastroenterology, cardiovascular diseases, chronic heart failure, RS1-441, Clinical Practice, genito-urinary infections, Pharmacy and materia medica, chemistry, Internal medicine, medicine, business, Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4cbfd45247d79d3473ffeb0a895dd8cTest
https://doi.org/10.32383/farmpol/143033Test -
4
المؤلفون: Edoardo Gronda, Massimo Iacoviello, Claudio Napoli, Pasquale Caldarola, Domenico Gabrielli, Furio Colivicchi, Stefano Urbinati, Edoardo Mannucci
المصدر: European Heart Journal Supplements : Journal of the European Society of Cardiology
مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, medicine.medical_specialty, Heart failure, chemistry.chemical_compound, Diabetes mellitus, Internal medicine, Type 2 diabetes mellitus, medicine, Empagliflozin, AcademicSubjects/MED00200, Dapagliflozin, Canagliflozin, Ejection fraction, business.industry, Type 2 Diabetes Mellitus, Articles, medicine.disease, chemistry, Cardiovascular death, Cardiology, Cardiology and Cardiovascular Medicine, business, Renal function, medicine.drug, Kidney disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2694f6672d64d5a4a407e85ca7efc4c8Test
https://doi.org/10.1093/eurheartj/suab066Test -
5
المؤلفون: Stuart J. Pocock, Daniel Cotton, Martina Brueckmann, Stefan D. Anker, James L. Januzzi, Gerasimos Filippatos, Waheed Jamal, Milton Packer, João Pedro Ferreira, Javed Butler, Tomoko Iwata, Faiez Zannad
المساهمون: BOZEC, Erwan, Baylor Heart and Vascular Institute, Baylor University Medical Center, Imperial College London, Division of Cardiology, Harvard Medical School and Massachusetts General Hospital, Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Department of Cardiology (CVK), and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Department of Medicine, University of Mississippi School of Medicine, National and Kapodistrian University of Athens (NKUA), Department of Medical Statistics, London School of Hygiene and Tropical Medicine, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim, Eli Lilly and Company.
المصدر: European Journal of Heart Failure
European Journal of Heart Failure, European Society of Cardiology (Wiley), 2021, 23 (9), pp.1529-1538. ⟨10.1002/ejhf.2256⟩مصطلحات موضوعية: medicine.medical_specialty, New York Heart Association Class, Empagliflozin, Renal function, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Glucosides, Troponin T, Diabetes mellitus, Internal medicine, medicine, Sodium-glucose co-transporter 2 inhibition, Humans, Benzhydryl Compounds, Heart Failure, Ejection fraction, biology, business.industry, Stroke Volume, Atrial fibrillation, Prognosis, medicine.disease, Troponin, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Heart failure, Cardiology, biology.protein, Cardiology and Cardiovascular Medicine, business, Biomarkers
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d7d06292ba1b4e6819c2c2708d9739Test
https://doi.org/10.1002/ejhf.2256Test -
6
المؤلفون: Tess Montada-Atin, G. V. Ramesh Prasad
المصدر: World Journal of Diabetes
مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, Review, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, Glucagon-like peptide-1 receptor agonists, Kidney transplantation, 03 medical and health sciences, 0302 clinical medicine, Dipeptidyl peptidase-4 inhibitors, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Post-transplant diabetes mellitus, education, education.field_of_study, business.industry, Oral antihyperglycemic drugs, Acute kidney injury, Cardiovascular disease, medicine.disease, Transplantation, Heart failure, business, Sodium glucose co-transporter 2 inhibitors
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6111ba72f2e18ba5c1fe30c56de1c10Test
https://doi.org/10.4239/wjd.v12.i5.541Test -
7Eligibility of outpatients with chronic heart failure for sodium–glucose co‐transporter‐2 inhibitors
المؤلفون: Giuseppina Piazzolla, Margherita Ilaria Gioia, Francesco Lisi, Gianmarco Angelini, Marco Matteo Ciccone, Massimo Iacoviello, Raffaella Ursi, Miriam Albanese, Maria Consiglia Bellino, Natale Daniele Brunetti, Giuseppe Parisi, Luca Amato
المصدر: ESC Heart Failure, Vol 8, Iss 4, Pp 2951-2958 (2021)
ESC Heart Failureمصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Population, Heart failure, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Original Research Articles, Internal medicine, Diabetes mellitus, Outpatients, Type 2 diabetes mellitus, medicine, Natriuretic peptide, Humans, Diseases of the circulatory (Cardiovascular) system, Original Research Article, 030212 general & internal medicine, education, Sodium-Glucose Transporter 2 Inhibitors, education.field_of_study, Ejection fraction, Symporters, business.industry, Sodium, Sodium–glucose co‐transporter inhibitor, Type 2 Diabetes Mellitus, medicine.disease, Glucose, RC666-701, Therapy, Cardiology and Cardiovascular Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15de8da86f21e8e91e18d7a313046c45Test
https://doi.org/10.1002/ehf2.13380Test -
8
المؤلفون: Lakshini Y. Herat, Márcio Galindo Kiuchi, Aaron L. Magno, Vance B. Matthews, Markus P. Schlaich, Natalie C. Ward, Elizabeth Rakoczy
المصدر: World Journal of Gastroenterology
مصطلحات موضوعية: medicine.medical_specialty, Succinate, Mouse, medicine.medical_treatment, Succinic Acid, Empagliflozin, Gut microbiota, Sodium glucose co-transporter inhibitors, Diabetes Mellitus, Experimental, Mice, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Sodium-Glucose Transporter 2, Diabetic retinopathy, Diabetes mellitus, Internal medicine, medicine, Animals, Humans, Dapagliflozin, Akimba, Type 1 diabetes, Kidney, Sodium glucose co-transporter 2, Chemistry, Pancreatic islets, Insulin, Sodium, Diabetes, Gastroenterology, General Medicine, Basic Study, medicine.disease, Renal glucose reabsorption, Mice, Inbred C57BL, Glucose, Endocrinology, medicine.anatomical_structure, 030220 oncology & carcinogenesis, 030211 gastroenterology & hepatology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dfa88aecdb23749065350323211219fTest
https://doi.org/10.3748/wjg.v26.i23.3225Test -
9
المؤلفون: Heerspink, H. J.L., Stefansson, B., Chertow, G., Correa-Rotter, R., Greene, Tom, Hou, Fan Fan, Lindberg, Magnus, McMurray, John, Rossing, P., Toto, Roberto, Langkilde, Anna Maria, Wheeler, David C., Wheeler, D. C., Greene, T., Hou, F. F., McMurray, J., Toto, R., Langkilde, A. M., Pfeffer, Marc A., Pocock, Stuart, Swedberg, Karl, Rouleau, Jean L., Chaturvedi, Nishi, Ivanovich, Peter, Levey, Andrew S., Christ-Schmidt, Heidi, Mann, Johannes, Held, Claes, Varenhorst, Christoph, Holmgren, Pernilla, Hallberg, Theresa, Douthat, Walter, Filho, Roberto Pecoits, Cherney, David, Persson, Frederik, Haller, Hermann, Wittmann, István, Khullar, Dinesh, Naoki, Kashihara, Correa-Rotter, Richardo, Escudero, Elizabeth, Isidto, Rey, Nowicki, Michal, Batiushin, Mikhail
المساهمون: Groningen Kidney Center (GKC), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET)
المصدر: Nephrology Dialysis Transplantation
Nephrology Dialysis Transplantation, 35(2), 274-282. Oxford University Press
Heerspink, H J L, Stefansson, B, Chertow, G, Correa-Rotter, R, Greene, T, Hou, F F, Lindberg, M, McMurray, J, Rossing, P, Toto, R, Langkilde, A M, Wheeler, D C, Heerspink, H J L, Wheeler, D C, Chertow, G, Correa-Rotter, R, Greene, T, Hou, F F, McMurray, J, Rossing, P, Toto, R, Stefansson, B, Langkilde, A M, Pfeffer, M A, Pocock, S, Swedberg, K, Rouleau, J L, Chaturvedi, N, Ivanovich, P, Levey, A S, Christ-Schmidt, H, Mann, J, Held, C, Varenhorst, C, Holmgren, P, Hallberg, T, Douthat, W, Filho, R P, Cherney, D, Hou, F F, Persson, F, Haller, H, Wittmann, I, Khullar, D, Naoki, K, Correa-Rotter, R, Escudero, E, Isidto, R, Nowicki, M, Batiushin, M & DAPA-CKD Investigators 2020, ' Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial ', Nephrology Dialysis Transplantation, vol. 35, no. 2, pp. 274-282 . https://doi.org/10.1093/ndt/gfz290Testمصطلحات موضوعية: Male, Type 2 diabetes, 030204 cardiovascular system & hematology, urologic and male genital diseases, sodium-glucose co-transporter inhibitor, law.invention, chemistry.chemical_compound, 0302 clinical medicine, Glucosides, Randomized controlled trial, law, Chronic kidney disease, Randomized controlled clinical trial, Clinical endpoint, Diabetic Nephropathies, 030212 general & internal medicine, Dapagliflozin, randomized controlled clinical trial, Aged, 80 and over, sodium–glucose co-transporter inhibitor, Middle Aged, Prognosis, Cardiovascular Diseases, Research Design, Nephrology, Female, Glomerular Filtration Rate, Adult, medicine.medical_specialty, Adolescent, Renal function, Young Adult, 03 medical and health sciences, Double-Blind Method, Clinical Research, Diabetes mellitus, Internal medicine, medicine, Humans, Benzhydryl Compounds, Renal Insufficiency, Chronic, Sodium-Glucose Transporter 2 Inhibitors, Aged, Transplantation, Creatinine, business.industry, dapagliflozin, medicine.disease, Sodiumglucose co-transporter inhibitor, Diabetes Mellitus, Type 2, chemistry, ORIGINAL ARTICLES, INHIBITORS, business, chronic kidney disease, Kidney disease
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d7ee7be4cfa9b1001a569aca9821c18Test
https://doi.org/10.1093/ndt/gfz290Test -
10
المؤلفون: Humeyra Rekali Sahin, Emre Durcan, Serdar Sahin, Zeynep Oşar Siva, Ozge Polat Korkmaz, Hasan Ilkova, Ozlem Haliloglu, Taner Damci, Volkan Yumuk
المصدر: Turkish Journal of Medical Sciences
مصطلحات موضوعية: Double-Blind, Male, medicine.medical_specialty, Beck Anxiety Inventory, Type 2 diabetes, Anxiety, Infections, sodium-glucose co-transporter 2 inhibitor, Article, Association, Quality of life, Weight loss, Sleep Initiation and Maintenance Disorders, Internal medicine, Diabetes mellitus, Prevalence, medicine, Adults, Humans, Hypoglycemic Agents, Sodium-Glucose Transporter 2 Inhibitors, Glycated Hemoglobin, business.industry, Sglt2 Inhibitors, Type 2 Diabetes Mellitus, sleep quality, General Medicine, Dapagliflozin, Middle Aged, medicine.disease, Hypoglycemia, Diabetes Mellitus, Type 2, quality of life, Health, Inadequate Glycemic Control, Female, medicine.symptom, business, Body mass index
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f41551a1fdd2fd6a15d9b32a1eb3f65cTest
https://doi.org/10.3906/sag-2008-37Test